AF
ONCY

Aviso Financial’s Oncolytics Biotech ONCY Stock Holding History

Aviso Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,304
Closed -$1.11K – 330
2026
Q1 		$1.11K Buy
1,304
+1,252
+2,408% +$1.25K ﹤0.01% 323
2025
Q4 		$45 Hold
52
– – ﹤0.01% 343
2025
Q3 		$72 Hold
52
– – ﹤0.01% 344
2025
Q2 		$39 Hold
52
– – ﹤0.01% 348
2025
Q1 		$28 Hold
52
– – ﹤0.01% 349
2024
Q4 		$48 Hold
52
– – ﹤0.01% 355
2024
Q3 		$46 Sell
52
-4
-7% -$4 ﹤0.01% 357
2024
Q2 		$55 Buy
+56
New +$61 ﹤0.01% 348

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Aviso Financial's ONCY Position: Q2 2026 in Review

Aviso Financial sold out of Oncolytics Biotech (ONCY) in Q2 2026, closing a stake of 1,304 shares — an estimated $1.11K sold.

Aviso Financial first reported a position in ONCY in Q2 2024 and held it in 8 quarters. The position peaked at $1.11K in Q1 2026. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Aviso Financial reported no remaining Oncolytics Biotech position as of Q2 2026 after selling out during the quarter.
  • Aviso Financial sold 1,304 Oncolytics Biotech shares in Q2 2026, an estimated $1.11K.
  • Aviso Financial first reported a position in Oncolytics Biotech in Q2 2024 and held it in 8 quarters.
  • Aviso Financial's Oncolytics Biotech position peaked at $1.11K in Q1 2026.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.